ZA94398B - Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation - Google Patents

Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation

Info

Publication number
ZA94398B
ZA94398B ZA94398A ZA94398A ZA94398B ZA 94398 B ZA94398 B ZA 94398B ZA 94398 A ZA94398 A ZA 94398A ZA 94398 A ZA94398 A ZA 94398A ZA 94398 B ZA94398 B ZA 94398B
Authority
ZA
South Africa
Prior art keywords
amidinophenyl
scr1
napthyl
amidino
ester
Prior art date
Application number
ZA94398A
Other languages
English (en)
Inventor
Danutha Ewa Irena Mossakowska
Richard Anthony Godwin Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA94398B publication Critical patent/ZA94398B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA94398A 1993-01-22 1994-01-20 Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation ZA94398B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition

Publications (1)

Publication Number Publication Date
ZA94398B true ZA94398B (en) 1994-11-15

Family

ID=10729169

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94398A ZA94398B (en) 1993-01-22 1994-01-20 Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation

Country Status (10)

Country Link
EP (1) EP0680332A1 (enExample)
JP (1) JPH08505867A (enExample)
CN (1) CN1118141A (enExample)
AU (1) AU5863694A (enExample)
CA (1) CA2153797A1 (enExample)
GB (1) GB9301289D0 (enExample)
NZ (1) NZ259737A (enExample)
TW (1) TW241203B (enExample)
WO (1) WO1994016719A1 (enExample)
ZA (1) ZA94398B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431194T2 (de) * 1993-10-21 2002-12-12 G.D. Searle & Co., Chicago Amidino-derivate nützlich als no synthase-hemmer
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
GB2095239B (en) * 1981-02-27 1985-03-06 Torii & Co Ltd Novel amidine compounds
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
EP0560929A1 (en) * 1990-12-06 1993-09-22 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
JPH08505867A (ja) 1996-06-25
EP0680332A1 (en) 1995-11-08
NZ259737A (en) 1997-04-24
WO1994016719A1 (en) 1994-08-04
CA2153797A1 (en) 1994-08-04
AU5863694A (en) 1994-08-15
GB9301289D0 (en) 1993-03-17
CN1118141A (zh) 1996-03-06
TW241203B (enExample) 1995-02-21

Similar Documents

Publication Publication Date Title
GB2280860B (en) Method and device for treating a parenteral emulsion-containing medicament
IL111189A (en) Protection switching apparatus and method
GB2274758B (en) Telephone systems and method of operation
PL299163A1 (en) Method of conducting lepaeoscopic operations in particular those of hernia and leparoscopic apparatus therefor
GB9608317D0 (en) A composition for preventing and treating kinetotia syndrome
AU5067290A (en) Method and apparatus for switching context of state elements in a microprocessor
AP9300598A0 (en) Compositions and method for waste treatment
HU9301272D0 (en) Method for treating inflammations and wounds using plasminogene activator inhibitors
GB9121665D0 (en) Sputtering processes and apparatus
AU3143289A (en) Protection and security apparatus and method
EP0583665A3 (en) Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis
AU1749592A (en) Method and device for treating myopia
AU7056894A (en) Skin treatment method utilizing a composition and a pad
EP0458309A3 (en) Dicyclopentadiene activation method and polymerization composition
AU7366791A (en) A method and a pharmaceutical preparation for treating pain
HUT76754A (en) Polymer scale preventive agent and process for producing a polymer
ZA94398B (en) Combination of a soluble complement receptor-1(scr1) and an amidinophenyl or amidino napthyl-ester for treating inflammation
ZA932483B (en) Method and composition for treating acne
HU9400290D0 (en) Pharmaceutical composition for preventing and treating retinal dieases
HU9302183D0 (en) Medical preparatives for preventing and treating osteoporises after menopausa
PL303845A1 (en) Agent for preventing formation of polymer precipitate and method of obtaining a polymer
AU6276494A (en) Method for treating colic and constipation
KR960016643B1 (en) Method and apparatus for reducing noise in a linked compressor-expander telecommunication system
AU6394194A (en) System and method for dispensing a treating material
GB9121659D0 (en) Sputtering processes and apparatus